4//SEC Filing
Minai-Azary Jennifer Lynn 4
Accession 0001842952-22-000021
CIK 0001842952other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 4:42 PM ET
Size
5.6 KB
Accession
0001842952-22-000021
Insider Transaction Report
Form 4
Minai-Azary Jennifer Lynn
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2022-02-25+112,470→ 112,470 totalExercise: $1.79Exp: 2032-02-24→ Common Stock (112,470 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 25, 2023, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining three years of the four-year period, subject to continued service with the Issuer.
Documents
Issuer
Context Therapeutics Inc.
CIK 0001842952
Entity typeother
Related Parties
1- filerCIK 0001844398
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 4:42 PM ET
- Size
- 5.6 KB